Fondaparinux Market, By Types (Branded and Generic), By End Use (Clinics, Hospitals, Ambulatory Surgical Centres, Diagnostic Centres and Home Care Settings), By Geography (North America, Europe, Asia Pacific, and Rest of the World) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The fondaparinux market was valued at USD 388.9 million by 2017, growing with 6.4% CAGR during the forecast period, 2018-2025.
Market Dynamics
Fondaparinux is a molecule that is widely used in the pharmaceutical industry. This particular molecule is used as an anticoagulant (prevents the development of blood clots) in the healthcare industry. This drug due to its molecular structure as compared to regular heparin shows more efficacy. It is majorly used in medical conditions such as knee or hip replacement, deep vein thrombosis (DVT) and Pulmonary Embolism (PE). Arixtra, a type of Fondaparinux is the U.S. FDA approved drug to treat cases of pulmonary embolism especially in cases of DVT surgeries.
The benefits it offers over heparin is one of the reasons why this particular therapeutic has grown in this specific industry. One of the significant factors that will drive the market growth is the increase in the number of cases in knee and hip replacement. Since OECD Health Statistics 2017, stated that on an average the cases of hip replacement increased 30% from the year 2000 to 2015. Anticoagulants are also provided to geriatric populations due to a number of complications that could arise due to age-related diseases.
On contrary, there is a significant amount of uncertainty when it comes to government regulations regarding the use of fondaparinux, pull back the industry growth. Furthermore, this product is not very commonly promoted by doctors due to its associated side effects such as breathing issues, allergic reactions, numbness and muscle weakness.
Types Takeaway
The two major segments for this are generic and branded. Fondaparinux has a generic form of it available as an injectable blood thinner, popularly known as Arixtra. One of the most common End Uses for this product is the treatment for DVT and pulmonary thromboembolism. This product is quite highly priced, one of the major reasons for it is due to an extremely difficult manufacturing process the drug has to go through. It is a highly stringent and complex process. This is also a reason why fondaparinux is consumed with limitations.
To a great extent, an improvement in the R&D facilities can drastically change the way these products are manufactured. Governments across the globe are promoting the practice of using generic drugs from a regulatory standpoint. Countries such as France, Japan, and Spain have all adopted policies that promote the use of these generic drugs as there is better control over the pricing for these as compared to branded products. From an end use perspective generally the drug is used in hospitals, clinics, ambulances, home care set ups and diagnostic facilities across the healthcare set up.
Regional Takeaway
An increase in the number of increased diseases, tumors, cardiovascular diseases in North Americas one of the reasons why North America is one of the leading users of the drug Fondaparinux. Illnesses such as haematological, neurological and CVD are increasingly predominant in North America. China is the second highest when it comes to consuming this product because the country is an evolving market from a pharmaceutical industry standpoint. It has been central when it comes to the manufacturing of various API’s from a global standpoint.
Key Vendor Takeaway
The key market players of this industry are GlaxoSmithKline Plc, Alchemia Ltd., Abbott Laboratories, Inc., Dr. Reddy’s Laboratories, Apotex, Inc., ScinoPharm Taiwan Ltd., Aurobindo Pharma and Lupin Pharmaceuticals. This is the consolidated industry, where handful companies capture significant revenue share.
Key players are engaged in new product introduction and merger and acquisitions to attract large customer base. For instance, in December 2017, Aurobindo Pharma received approval of Fondaparinux Sodium injection (5 mg/0.4 mL, 2.5 mg/0.5 mL, 10 mg/0.8 mL and 7.5 mg/0.6 mL single-dose prefilled syringes) from the US Food & Drug Administration (USFDA).
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TYPE
- Branded
- Generic
MARKET, BY END USE
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Care Settings
- Clinics
- Hospitals
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. FONDAPARINUX MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by End Use
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. FONDAPARINUX KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. FONDAPARINUX INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. FONDAPARINUX MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. FONDAPARINUX MARKET – BY TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Type, 2017 & 2025 (%)
6.2. Branded
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Generic
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. FONDAPARINUX MARKET – BY END USE
7.1. Overview
7.1.1. Segment Share Analysis, By End Use, 2017 & 2025 (%)
7.2. Ambulatory Surgical Centres
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Diagnostic centres
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Home Care Settings
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Clinics
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6. Hospitals
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. FONDAPARINUX MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2017 & 2025 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
8.2.4. North America Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
8.2.5. North America Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
8.3.5. Europe Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.3.6. France
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.7. Germany
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.8. Rest of Europe
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.4.6. China
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.7. India
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.8. Rest of APAC
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Key Manufacturers in Rest of the World
8.5.3. Rest of the World Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
8.5.4. Rest of the World Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
8.5.5. Rest of the World Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.5.6. Latin America
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.7. Middle East and Africa
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. GlaxoSmithKline Plc
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Alchemia Ltd.
9.3. Abbott Laboratories, Inc.
9.4. Dr. Reddy’s Laboratories
9.5. Apotex, Inc.
9.6. ScinoPharm Taiwan Ltd.
9.7. Aurobindo Pharma
9.8. Lupin Pharmaceuticals
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Fondaparinux market: Type snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Fondaparinux market, by Type 2014-2025 (USD Million)
TABLE Fondaparinux market: End Use snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End Use
TABLE Global Fondaparinux market, by End Use 2014-2025 (USD Million)
TABLE Fondaparinux market: Regional Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Fondaparinux market, by Region 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by Country, 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE U.S. Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE U.S. Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Canada Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Canada Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Germany Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Germany Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE U.K. Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE U.K. Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of the Europe Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of the Europe Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Japan Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Japan Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE China Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE China Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of Asia Pacific Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of Asia Pacific Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Latin America Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Latin America Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Middle East and Africa Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Middle East and Africa Fondaparinux market, by End Use, 2014-2025 (USD Million)
List of Figures
FIGURE Fondaparinux market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Type segment market share analysis, 2017 & 2025
FIGURE Type segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Braned market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Generics market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE End Use segment market share analysis, 2017 & 2025
FIGURE End Use segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Ambulatory surgical centres market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Diagnostic centres market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Home care settings market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Clinics market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Hospitals market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Regional segment market share analysis, 2017 & 2025
FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE North America Fondaparinux market share and leading players, 2018
FIGURE Europe Fondaparinux market share and leading players, 2018
FIGURE Asia Pacific Fondaparinux market share and leading players, 2018
FIGURE Latin America Fondaparinux market share and leading players, 2018
FIGURE Middle East and Africa Fondaparinux market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Europe market share analysis by country, 2018
FIGURE U.K. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Asia Pacific market share analysis by country, 2018
FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of Asia Pacific market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of the World market share analysis by country, 2018
FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
